Z-endoxifen show promise as new treatment

Options

https://www.sciencedaily.com/releases/2017/08/170830202125.htm

"The primary goal of the study was to safely deliver therapeutic levels of endoxifen without the requirement for CYP2D6 liver metabolism," says Dr. Goetz. "However, one of the most surprising observations was the prolonged anticancer benefit, [which] in some cases lasted more than two years in women who had progressed on standard anti-estrogen therapies."


Comments

Categories